Hälsa & medicin

Swedish researchers have established InfCareHIV, a comprehensive registry tracking people living with diagnosed HIV across the country. The prospective cohort study will provide real-world data on treatment effectiveness, complications, and survival—critical intelligence for healthcare systems planning HIV services and pharmaceutical companies developing new therapies.EN

Researchers discovered that the brain region controlling movement actively reshapes how it processes sensory information while we move. The finding could reshape understanding of motor control and inform treatment strategies for movement disorders affecting millions of workers and aging populations.EN

Protective T cell responses generated early in life against SARS-CoV-2 weaken significantly over time, researchers report in PNAS. The finding has implications for vaccine strategy and long-term immunity expectations, particularly for vulnerable populations relying on childhood-acquired protection.EN

Researchers have identified a mechanism by which Helicobacter pylori — a bacterium infecting roughly half the world's population — may trigger hardening of coronary arteries. The finding could reshape how physicians screen for and treat H. pylori infections, particularly in patients at cardiovascular risk.EN

A new Scandinavian study identifies significant differences in how registered nurses and nursing assistants handle missed care tasks—a critical marker of hospital quality and patient safety. The findings could reshape staffing decisions and training protocols for healthcare systems managing costs while maintaining care standards.EN

Swedish researchers tracked twins and siblings over 10 years to identify which psychiatric conditions reliably forecast long-term clinical problems. The findings could help healthcare systems and insurers better predict patient trajectories and allocate treatment resources before conditions worsen.EN

Researchers found that different mutations in the desmin protein—which causes muscular dystrophy—break the cell's autophagy system through distinct mechanisms. The discovery suggests that one-size-fits-all drug approaches may fail, and personalized treatments targeting specific mutations could be necessary to restore muscle function.EN

A new study in JAMA Otolaryngology reveals that people with a parent or sibling surgically treated for cholesteatoma—a serious ear infection—face elevated risk of developing the condition themselves. The finding could reshape clinical screening practices and affects how ear specialists counsel families, with implications for healthcare systems planning preventive care strategies.EN

European researchers discovered a significant gap between how much exercise people with inflammatory joint diseases say they do and what their activity trackers actually record. The mismatch could undermine clinical decision-making and public health strategies that rely on patient surveys rather than objective measurements.EN

Researchers have identified distinct gene dysregulation patterns in lupus patients that could enable precision medicine approaches—tailoring treatment to individual genetic profiles rather than one-size-fits-all therapy. For pharmaceutical companies and healthcare systems, this finding opens a pathway to develop targeted drugs and reduce costly trial-and-error treatment cycles in a disease affecting nearly 1.5 million Americans.EN

Osimertinib, a targeted therapy for lung cancer with brain metastases, penetrates brain tissue more effectively than previously thought, according to imaging data. The finding could reshape treatment decisions for thousands of patients and influence how drugmakers design cancer therapies to cross the blood-brain barrier.EN

A new study finds that preterm births and stillbirths rose sharply during the pandemic, but the increases were concentrated in lower-income communities. The findings signal that healthcare access disparities, not the virus alone, drove worse pregnancy outcomes—a pattern with lasting implications for public health policy and maternal health investment.EN

A new multi-country study quantifies how often frontotemporal lobar degeneration—a devastating form of early-onset dementia—strikes Europeans, providing the first standardized incidence data across nine nations. The findings could reshape healthcare planning and drug development priorities for a disease that typically strikes people in their 50s and 60s.EN

A new study reveals that injured people's sense of wellbeing shifts dramatically as they adapt to their condition—a finding that challenges how healthcare systems measure treatment success. Understanding this 'response shift' could reshape how insurers, employers, and policymakers assess rehabilitation outcomes and plan long-term care strategies.EN

Researchers found that C21, an oral medication targeting angiotensin II receptors, reduced pulmonary hypertension in animal models. The finding could open a new treatment pathway for a condition that currently has limited options and affects thousands of patients globally, potentially creating market opportunities for pharmaceutical developers.EN

A Swedish hospital trial of inhaled ciclesonide—a common asthma medication—found it did not reduce time on oxygen therapy for COVID-19 patients, compared to standard care. The finding contradicts earlier optimism about repurposing the drug and has implications for treatment protocols and pharmaceutical development strategies.EN

Researchers discovered that polycystic ovary syndrome in mothers transmits reproductive and metabolic dysfunction to male offspring, suggesting the condition's effects span generations. The finding could reshape how clinicians counsel women with PCOS about family health risks and inform preventive strategies for affected families.EN

Researchers found that a protein called eEF2 significantly improves how the body repairs dense connective tissues by controlling cell death, growth, and movement. The discovery could lead to new treatments for chronic wounds and surgical recovery, with potential applications across wound care, orthopedics, and regenerative medicine industries.EN

A comprehensive analysis of diabetes medications shows that while many drugs lower blood sugar effectively, they carry different risks and benefits that doctors and patients often overlook. The findings could force insurers and healthcare systems to reconsider which treatments they prioritize and how they price these widely-used medications.EN

A Swedish hospital tracked patients who underwent pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension, a rare and previously untreatable condition. The findings demonstrate that surgery can meaningfully improve functional outcomes, potentially reshaping treatment pathways and reducing long-term care costs for this patient population.EN

Researchers have developed a method to forecast disease progression in multiple sclerosis patients, potentially allowing earlier interventions to prevent disability. The advance could reshape how neurologists monitor MS and help pharmaceutical companies design more targeted clinical trials.EN

Researchers documented a striking case where damage to the optic nerve in a young patient led to severe tunnel vision through a cascade of cell death in the retina. The finding underscores how early neurological injuries can have delayed consequences—a concern for pediatric care protocols and long-term patient monitoring strategies.EN

A Swedish twin study reveals that avoidant restrictive food intake disorder — a condition affecting how children eat — stems largely from inherited traits rather than parenting or psychology alone. The finding could reshape how clinicians diagnose and treat the disorder, potentially reducing misdiagnosis and improving outcomes for millions of families.EN

A new study confirms that pregnant women with systemic lupus erythematosus can safely receive COVID-19 vaccines without triggering disease flares. The finding removes a major barrier to vaccination in this vulnerable population and informs clinical guidelines for immunizing pregnant patients with autoimmune conditions.EN

A study of 83 published patient-driven health innovations found that 78% reported no measurable outcomes for patients or the healthcare system. Researchers say the gap signals a missed opportunity for understanding which patient-designed solutions actually work—and where health systems should invest resources.EN